Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2019, Article ID 6705949, 10 pages
https://doi.org/10.1155/2019/6705949
Research Article

Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors

1Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic
2CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006 Prague 5, Czech Republic

Correspondence should be addressed to Michal Šmahel; zc.inuc.rutan@mlehams

Received 31 July 2018; Revised 12 November 2018; Accepted 21 November 2018; Published 11 February 2019

Guest Editor: Jianjun Zhang

Copyright © 2019 Ingrid Poláková et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Drakes and P. Stiff, “Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy,” ImmunoTargets and Therapy, vol. 2014, pp. 151–165, 2014. View at Publisher · View at Google Scholar
  2. S. Menon, S. Shin, and G. Dy, “Advances in cancer immunotherapy in solid tumors,” Cancers, vol. 8, no. 12, p. 106, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. W. H. Fridman, L. Zitvogel, C. Sautès–Fridman, and G. Kroemer, “The immune contexture in cancer prognosis and treatment,” Nature Reviews Clinical Oncology, vol. 14, no. 12, pp. 717–734, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Pagès, A. Kirilovsky, B. Mlecnik et al., “In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer,” Journal of Clinical Oncology, vol. 27, no. 35, pp. 5944–5951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. A. Ascierto, M. Capone, W. J. Urba et al., “The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment,” Journal of Translational Medicine, vol. 11, no. 1, p. 54, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Bercovici and A. Trautmann, “Revisiting the role of T cells in tumor regression,” OncoImmunology, vol. 1, no. 3, pp. 346–350, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Thoreau, H. X. L. Penny, K. W. Tan et al., “Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site,” Oncotarget, vol. 6, no. 29, pp. 27832–27846, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. H. Spitzer and G. P. Nolan, “Mass cytometry: single cells, many features,” Cell, vol. 165, no. 4, pp. 780–791, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Leelatian, D. B. Doxie, A. R. Greenplate et al., “Single cell analysis of human tissues and solid tumors with mass cytometry,” Cytometry Part B: Clinical Cytometry, vol. 92, no. 1, pp. 68–78, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Kaštánková, I. Poláková, M. Dušková, and M. Šmahel, “Combined cancer immunotherapy against Aurora kinase A,” Journal of Immunotherapy, vol. 39, no. 4, pp. 160–170, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Partlová, J. Bouček, K. Kloudová et al., “Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma,” OncoImmunology, vol. 4, no. 1, article e965570, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Lai, R. Ong, J. Li, and S. Albani, “A CD45-based barcoding approach to multiplex mass-cytometry (CyTOF),” Cytometry Part A, vol. 87, no. 4, pp. 369–374, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Mallone, S. I. Mannering, B. M. Brooks-Worrell et al., “Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society,” Clinical & Experimental Immunology, vol. 163, no. 1, pp. 33–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Nagel, C. Möbs, H. Raifer, H. Wiendl, M. Hertl, and R. Eming, “CD3-positive B cells: a storage-dependent phenomenon,” PLoS One, vol. 9, no. 10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Leelatian, D. B. Doxie, A. R. Greenplate, J. Sinnaeve, R. A. Ihrie, and J. M. Irish, “Preparing viable single cells from human tissue and tumors for cytomic analysis,” Current Protocols in Molecular Biology, vol. 118, no. 1, pp. 25C.1.1–25C.1.23, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Bodenmiller, E. R. Zunder, R. Finck et al., “Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators,” Nature Biotechnology, vol. 30, no. 9, pp. 858–867, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. E. R. Zunder, R. Finck, G. K. Behbehani et al., “Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm,” Nature Protocols, vol. 10, no. 2, pp. 316–333, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Catena, A. Özcan, N. Zivanovic, and B. Bodenmiller, “Enhanced multiplexing in mass cytometry using osmium and ruthenium tetroxide species,” Cytometry Part A, vol. 89, no. 5, pp. 491–497, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. H. E. Mei, M. D. Leipold, A. R. Schulz, C. Chester, and H. T. Maecker, “Barcoding of live human peripheral blood mononuclear cells for multiplexed mass cytometry,” The Journal of Immunology, vol. 194, no. 4, pp. 2022–2031, 2015. View at Publisher · View at Google Scholar · View at Scopus